International Holdings Company

International Holding Company is a large Abu Dhabi-based publicly listed investment holding company with a highly diversified portfolio spanning asset management, healthcare, real estate, technology, food, utilities, marine, and financial services. The group operates primarily as an owner, investor, and portfolio manager rather than as a dedicated biotechnology, pharmaceutical, or healthcare operating company. While it has meaningful exposure to healthcare through portfolio companies such as PureHealth and other healthcare-related subsidiaries, IHC itself is not a life sciences drug developer and does not appear to maintain a therapeutic R&D pipeline. The company has grown into one of the largest investment companies in the region, with more than 1,300 subsidiaries and listed entities across multiple sectors. For biotech analyst purposes, IHC is best understood as a diversified strategic holding company with healthcare investments rather than a pure-play healthcare or biotech company.